相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Basis of Cardioprotection by Erythropoietin
D. Burger et al.
Current Molecular Pharmacology (2010)
Role of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion
Dylan Burger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Erythropoietin treatment in patients with chronic heart failure: a meta-analysis
P. van der Meer et al.
HEART (2009)
Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study
Anho Liem et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Erythropoietin Protects the Heart from Ventricular Arrhythmia during Ischemia and Reperfusion via Neuronal Nitric-Oxide Synthase
Dylan E. Burger et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Effects of erythropoietin after an acute myocardial infarction: Rationale and study design of a prospective, randomized, clinical trial (HEBE III)
Anne M. Belonje et al.
AMERICAN HEART JOURNAL (2008)
Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol-3 kinase and ERK1/2 activation
N. R. Mudalagiri et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia
B. Daan Westenbrink et al.
CARDIOVASCULAR DRUGS AND THERAPY (2008)
Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia
Jalal K. Ghali et al.
CIRCULATION (2008)
Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit
Erik Lipsic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response
M. Brines et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Sly as a FOXO: New paths with forkhead signaling in the brain
Kenneth Maiese et al.
CURRENT NEUROVASCULAR RESEARCH (2007)
Mechanisms of disease: Myocardial reperfusion injury
Derek M. Yellon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia
Dirk J. van Veldhuisen et al.
EUROPEAN HEART JOURNAL (2007)
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization
B. Daan Westenbrink et al.
EUROPEAN HEART JOURNAL (2007)
Positive effect of darbepoetin on peri-infarction remodeling in a porcine model of myocardial ischemia-reperfusion
Catalin Toma et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction
Maurizio Ferrario et al.
EUROPEAN HEART JOURNAL (2007)
Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart
Erhe Gao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Protective role of endogenous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice
Yasuhide Asaumi et al.
CIRCULATION (2007)
Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity
Z. Z. Chong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure - A randomized, double-blind, placebo-controlled trial
Piotr Ponikowski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
Arintaya Phrommintikul et al.
LANCET (2007)
Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells
Fabrice Prunier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Etiology of anemia in patients with advanced heart failure
John N. Nanas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Protective effects of erythropoietin in cardiac ischemia - From bench to bedside
Erik Lipsic et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic pepticle and hospitalization in patients with heart failure and anemia
Alberto Palazzuoli et al.
AMERICAN HEART JOURNAL (2006)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
Tilman B. Drueke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase
Dylan Burger et al.
CARDIOVASCULAR RESEARCH (2006)
Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure
Yiwen Li et al.
CARDIOVASCULAR RESEARCH (2006)
Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3β
Masahiro Nishihara et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Anemia, renal dysfunction, and their interaction in patients with chronic heart failure
Ramesh de Silva et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs
Akio Hirata et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients
Julia Bohlius et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities
TR Coleman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: A randomized feasibility and safety study
Erik Lipsic et al.
CARDIOVASCULAR DRUGS AND THERAPY (2006)
Anemia, chronic renal disease and congestive heart failure - the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists
Donald S. Silverberg et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2006)
Cell life versus cell longevity: The mysteries surrounding the NAD(+) precursor nicotinamide
FQ Li et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI 3-kinase-dependent manner
J George et al.
CARDIOVASCULAR RESEARCH (2005)
Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: Dose response and therapeutic window
C Moon et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: Darbepoetin alfa study, ECHOS, and ASCOT-BPLA
JGF Cleland et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction
P van der Meer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Circulating erythropoietin levels and prognosis in patients with congestive heart failure - Comparison with neurohormonal and inflammatory markers
J George et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Emerging biological roles for erythropoietin in the nervous system
M Brines et al.
NATURE REVIEWS NEUROSCIENCE (2005)
High serum erythropoletin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention
S Namiuchi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction
A Ishani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease
ZZ Chong et al.
PROGRESS IN NEUROBIOLOGY (2005)
Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts
A Hirata et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
New avenues of exploration for erythropoietin
K Maiese et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Anemia in chronic heart failure: Pathogenetic mechanisms
DO Okonko et al.
JOURNAL OF CARDIAC FAILURE (2004)
Erythropoietin regulates endothelial progenitor cells
FH Bahlmann et al.
BLOOD (2004)
Derivatives of erythropoietin that are tissue protective but not erythropoietic
M Leist et al.
SCIENCE (2004)
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure
P van der Meer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9
ZZ Chonga et al.
EXPERIMENTAL CELL RESEARCH (2004)
Erythropoietin in the brain: can the promise to protect be fulfilled?
K Maiese et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats
C Moon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway
AF Tramontano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury
ZQ Cai et al.
CIRCULATION (2003)
Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis
J Shibata et al.
BLOOD (2003)
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
L Calvillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8
ZZ Chong et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
The pleiotropic effects of erythropoietin in the central nervous system
M Buemi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure
DM Mancini et al.
CIRCULATION (2003)
The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron
DS Silverberg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases
ZZ Chong et al.
CIRCULATION (2002)
Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality
N Suzuki et al.
BLOOD (2002)
Erythropoietin and VEGF exhibit equal angiogenic potential
K Jaquet et al.
MICROVASCULAR RESEARCH (2002)
Cytokine and cytokine receptor pleiotropy and redundancy
K Ozaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells
RA Ashley et al.
PEDIATRIC RESEARCH (2002)
Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells
F Ammarguellat et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study
DS Silverberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits
K Noguchi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway
T Akimoto et al.
KIDNEY INTERNATIONAL (2000)
分享论文
